JUL 22, 2020 10:00 AM PDT

Molecular Diagnostic Solutions in a Pandemic: Planning for the 2020/2021 Flu Season with the Implementation of the ePlex® Respiratory Pathogen Panel 2

Sponsored by: GenMark Dx
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor of Pathology, Director, Molecular Virology, Johns Hopkins Medicine
    Biography
      Dr. Heba Mostafa completed her M.D. at the Faculty of Medicine, Alexandria University, Egypt in 2004 which was followed by a period of training and residency in clinical pathology. After completion of her M.D., she moved to the United States where she earned her Ph.D. in Microbiology in 2014 at the University of Kansas. In the 3 years following, she completed a Post-Doctoral Research Fellowship at St. Jude Children's Research Hospital where she focused on studying the pathogenesis, spread, and clearance of parainfluenza and influenza viruses in immunocompromised hosts.

      Upon completion of her research fellowship, Dr. Mostafa completed a two year Clinical Microbiology Fellowship at the University of Rochester Medical Center (URMC), where she was involved in the implementation of whole genome sequencing in the clinical microbiology laboratory. After her two year fellowship, she became board certified in Medical Microbiology by the American Society for Microbiology.

      While large amounts of her work have been presented and published on many topics, her current research interests include genomic surveillance of viruses and the correlation between viral evolution and disease severity. Dr. Mostafa is keen to understand more about the respiratory virome and developing personalized molecular diagnostic panels for immunocompromised populations as well as implementation of innovative molecular diagnostics in the clinical microbiology laboratory.

      Currently, she is the Director of Molecular Virology and an Associate Professor of Pathology at Johns Hopkins Medicine where she has been at the forefront of the pandemic, managing routine respiratory pathogen testing for Johns Hopkins and implementation of SARS-CoV-2 testing. In the rapidly evolving diagnostic landscape of 2020, Dr. Mostafa's interests are focused on developing future testing algorithms for respiratory pathogens that include SARS-CoV-2 to continually meet the needs of patient care.

    Abstract

    DATE: July 22, 2020

    TIME:  10:00 am PDT

     

    The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnostic testing became clear while many other factors regarding implementation and the future of testing remained in limbo with questions unanswered.

    Many laboratorians alongside their clinical colleagues have had to implement solutions for their patients that made the most sense and were the best fit for their institution.  This has led to building a laboratory test ordering framework which includes multiple platforms for SARS-CoV-2 testing to co-exist with other respiratory pathogen tests already in place, as the influenza season began to trail off. 

    Dr. Heba Mostafa and her team have taken a non-conventional approach to guide and build a testing algorithm for the detection of SARS-CoV-2 and other respiratory pathogens at the Johns Hopkins Virology Laboratory. In this webinar, she will detail her experience, early on, in the pandemic for SARS-CoV-2 testing and the considerations taken for using different testing methods. She will also highlight how the implementation of the ePlex Respiratory Pathogen Panel 2 will aid in the screening of 18 respiratory pathogens, including SARS-CoV-2, to further alleviate the burden on the laboratory as the next influenza season approaches, while providing the clinical team and ultimately patients, the results they need in a rapid actionable time frame.
     

     

    Learning Objectives:

    • Examine the ever changing landscape of laboratory testing for SARS-CoV-2 and other respiratory pathogens in a pandemic setting 
    • Extrapolate how a laboratory might consider algorithm changes with evolving technology and testing options
    • Conceptualize how a broad respiratory pathogen panel with the inclusion of SARS-CoV-2 will improve laboratory efficiency and get clinicians the results they need quickly

     

     

    Webinars will be available for unlimited on-demand viewing after live event.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


    Show Resources
    You May Also Like
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources
    Attendees
    • See more